Hatter Horizon Series 2018: Multimedia

Monday 10th December 2018

Videos of the presentations will be posted where when available.

Reducing the global burden of diabetes & cardiovascular disease: is there a role for governments?
Professor Dinky Levitt
University of Cape Town, South Africa

---

How will genetics impact on prevention and treatment of type 2 diabetes?
Professor Mark McCarthy
Oxford Centre for Diabetes, University of Oxford, UK

---

The biology and therapeutic potential of GLP-1 - another year on!
Professor Daniel Drucker
University of Toronto, Canada

---

The biology and therapeutic potential of SGLT2 inhibition - another year on!
Professor Nikolaus Marx
University of Aachen, Germany

---

SGLT2 Outcome trials - an evolving story
Professor Stephen Wiviott
Brigham & Women's Hospital, Boston, USA

---

Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes - i.e. weight management?
Professor Melanie Davies
Diabetes Research Centre, University of Leicester, UK

---

Is it time to rethink HbA1c?
Dr Dev Singh
New Cross Hospital, Wolverhampton, UK

---

How do SGLT2 inhibitors benefit the kidney?
Professor David Wheeler
University College London

---

Is there still a place for sulphonylureas?
Professor Cliff Bailey
Aston University, Birmingham, UK

---